top of page

GENESIS TRIAL

Doctor and patient

Enrolment has now closed.

​

We have reached our recruitment goals and are aiming to have the study finished early 2025. 

​

Schneider Von Gunn Pharmaceuticals has received Human Research Ethics Committee approval to commence the Genesis Trial. The Genesis Trial is a 4 week double-blind randomised placebo-controlled clinical trial to investigate the efficacy of CBD oil for the management of abdominal pain in patients suffering from Irritable Bowel Syndrome (IBS).

​

​

Minimum requirements to apply:

​

  • Must be at least 18 years of age at the time of consent.

  • Meets Rome IV criteria for IBS.

  • The abdominal pain should be present for at least 1 day per week for the last 3 months and the origin of the symptoms should be at least 6 months prior.

 

For more information or to apply, please fill out the form below.

bottom of page